http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012149936-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8921f8a1570ecad31dbd754f8ef7ae5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d83c4a7e44b4f54f0ebc5846af7bb076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ca0637464582cbcb4a7d310a0fa1256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a120740c4eb48966ca0c793caf699c65 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-35 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56905 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-533 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_293197017b8662e67be362b7a696686a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d40d492f7ec8b2f48ded5e36846ec30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20adbda77e8eecc6c48b1513810af57d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2686773d3666cbd4f28a42787892f69a |
| publicationDate | 2013-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2012149936-A3 |
| titleOfInvention | System for identification of microorganism and detection of infectious disorder |
| abstract | Methods for the identification of microorganisms or infectious disorders are disclosed, comprising obtaining a suitable sample from sources such as persons, animals, plants, food, water or soil. The methods also comprise providing tailored nucleic acid substrate(s) designed to react with a type 1 topoisomerase from one or more microorganism(s) or infectious agent(s), and incubating said substrate with said sample, or extracts or preparations from the sample, so that the substrate is processed by said topoisomerase if said microorganism(s) or infectious agent(s) is present in the sample. Finally, processed substrates are identified and potentially quantified by one or more of a range of standard molecular biology methods and read-out systems. The identification and potential quantification of microorganisms and infectious agents, including but not limited to Plasmodium falciparum and Mycobacterium tuberculosis, in single or multiplexed formats enable diseases to be diagnosed, treated, or prevented through the identification of potentially harmful organisms. This disclosure includes also follow-up tests or continued monitoring to evaluate responses to treatment or eradication efforts. In a further aspect the technology enables the testing of medical or chemical treatments designed to cure or prevent diseases based upon drugs targeting type 1 topoisomerases. Finally, the reagents and platforms needed for said purposes can be compiled from loose parts or provided as user-friendly kits, potentially enabling home testing for a multitude of microorganisms or infectious agents. |
| priorityDate | 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.